OnCusp Therapeutics Stock

www.oncusptx.comHealthcare / BioTech & PharmaFounded: 2021

OnCusp Therapeutics is an oncology treatment development company. With a mission to help cancer patients across the globe, OnCusp Therapeutics conducts biopharmaceutical and clinical trials to advance the medical tools and technologies available to patients worldwide. OnCusp Therapeutics was founded by Andy Fu, Bing Yuan, and Eric Slosberg in 2021 and is headquartered in New York, New York.

Register To Buy and Sell Shares

For more details on financing and valuation for OnCusp Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access OnCusp Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like OnCusp Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

OnCusp Therapeutics’ stock FAQs


Can you buy OnCusp Therapeutics’ stock?

OnCusp Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy OnCusp Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell OnCusp Therapeutics’ stock?

Yes, you can sell stock of a private company like OnCusp Therapeutics. Forge can help you sell your OnCusp Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is OnCusp Therapeutics’ stock price?

OnCusp Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access OnCusp Therapeutics’ private market stock price with Forge Data.

What is OnCusp Therapeutics’ stock ticker symbol?

OnCusp Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients

In Series A funding, OnCusp Therapeutics raised $100 million led by investments from Novo Holdings, F-Prime Captial, and OrbiMed.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.